Introduction {#sec1}
============

The incidence of prosthetic joint infection (PJI) in the UK for both hips and knees is approximately 0.6% [@bib1]. Both the high morbidity and mortality and the economic impact make accurate diagnosis and adequate treatment a priority. Staphylococci are responsible for the majority of PJI cases. *Staphylococcus lugdunensis* is a coagulase-negative staphylococcus (CoNS) that causes a variety of serious infections including PJI [@bib2].

Small-colony variants (SCVs) are members of the bacterial biofilm phenotype characterized by slow growth in small colonies approximately one-tenth the size of the parent strain. SCVs emerge as a result of genetic mutations or metabolic variations due to stress arising from nutrient limitation or exposure to sublethal concentrations of antibiotics [@bib3]. The presence of SCVs has implications for microbiological diagnosis, clinical presentation, and subsequent management [@bib4].

In this report, SCV of *S lugdunensis* was recovered from an infected knee replacement.

Case history {#sec2}
============

O.A. is a 50-year-old female with a long history of knee problems and was admitted with pain around her right knee where arthroplasty was performed and a draining sinus. Her previous history included an arthroscopic lateral release in 2003, patellar chondroplasty in 2005, a Fulkerson\'s osteotomy in 2007, removal of tibial screws in 2007, and a right total knee replacement (TKR) in 2014. After the knee replacement, she required 2 manipulations under anesthesia, the most recent in May 2016. In September 2016, she presented to the emergency department with an increase in pain and a draining sinus that had progressed from an area of induration a few days earlier. Her C-reactive protein was 30 mg/L and erythrocyte sedimentation rate was 42 mm/h.

On October 11, 2016, she underwent a first-stage revision of the TKR. Multiple tissue samples and the explanted prosthesis (femoral, tibial, and patellar implants) were sent for microbiological culture and sensitivity. In the laboratory, tissues were homogenized and cultured, and the all the removed prosthesis was sonicated, and the sonicates were cultured. After 48 hours of incubation, tissue samples grew 30-40 cfu/mL of *S lugdunensis*, and the sonicates grew 350 cfu/mL of full-size parent colonies scattered on a background of a much larger number of SCVs which were not clearly evident until 72 hours of incubation ([Fig. 1](#fig1){ref-type="fig"}). Both strains had similar antibiotic susceptibility profiles. If only the larger parent colonies were considered, this could have been seen as probable CoNS contamination. Matrix-assisted laser desorption ionization--time of flight mass spectroscopy showed that both parent and SCVs were indistinguishable and were *S lugdunensis*.Figure 1(a) Culture of the sonicate from the removed prosthesis on blood agar after 72 hours of incubation, showing large colonies surrounded by high numbers of very small colonies. The marked square is magnified 10 times in (b) to show the small colonies more clearly.

At the revision surgery, while the femoral and patellar components were well fixed, the tibial component was grossly loose. Following debridement, an articulating spacer was created using a standard press-fit condylar Sigma TKR prosthesis (DePuy Synthes, Warsaw, IN). The tibial component had a small cemented stem to provide additional diaphyseal support, and the knee was cemented in place using Palacos R+G (Heraeus Medical, Wehrheim, Germany) with 2 g of vancomycin added. The sinus was excised and wound primarily closed.

After the surgery, she was initially treated with 2 g of ceftriaxone and 600 mg of rifampicin per day, but the ceftriaxone was changed to 800 mg of teicoplanin per day after 5 weeks due to a rash associated with ceftriaxone. After a 6-week course of intravenous antibiotics, a further 6 weeks of oral flucloxacillin 4 g and rifampicin 600 mg per day were prescribed.

The patient has done well after her revision and finds that the articulating spacer provides her with adequate function. She has therefore not yet proceeded to the second stage and she has been followed up for a year at the time of preparation of this report (12 months of follow-up). Her C-reactive protein and erythrocyte sedimentation rate have returned to normal, and the wound has completely healed.

Discussion {#sec3}
==========

*S lugdunensis* is known to colonize the inguinal region and perineum [@bib5]. It was first described in 1988 [@bib6], and since then, it has been identified as a pathogen causing a wide variety of infections throughout the human body [@bib7].

*S lugdunensis* can produce clumping factor (bound coagulase) and hence can be misidentified as *S aureus* if the slide coagulase test is used rather than the tube test [@bib8]. This misidentification has been reported in literature and can be compounded by yellow pigment and DNAse production by some strains [@bib9]. The appearance of SCV can also give an impression of mixed culture, with possible interpretation of contamination. The phenotypic changes in *S lugdunensis* SCV can also give rise to misidentification as *S hominis* or other CoNS in certain commercial identification systems [@bib10], [@bib11]. In such situations, matrix-assisted laser desorption ionization--time of flight mass spectroscopy is able to provide more confident identification [@bib9], [@bib12], [@bib13]. *S lugdunensis* resembles *S aureus* in pathogenicity [@bib2]. In addition, *S lugdunensis* isolates are usually β-lactamase deficient and susceptible to penicillins [@bib14]. Hence, recognition of SCV and species identification of *S lugdunensis* is crucial for proper treatment. Although being clonally similar, their biochemical characterization and antibiotic susceptibilities can vary. Therefore, antibiotic susceptibility testing should be done for each phenotype separately [@bib15]. SCVs of *S aureus hemB* mutants have been shown to exhibit more adhesiveness to surfaces than the parent strain [@bib16]. Furthermore, development of SCV has been shown to be induced by the slow pattern of antibiotic release from gentamicin beads in patients with osteomyelitis [@bib17].

*S lugdunensis* appears to have a preference to infect knees more than hips. Among the *S lugdunensis* PJI episodes (summarized in [Table 1](#tbl1){ref-type="table"}), we could identify the site of infection in 84, among which 58 (69%), 24 (28.6%), and 2 (2.4%) episodes were in knees, hips, and other sites, respectively. This observation was previously made by the authors of the largest 2 series of *S lugdunensis* PJI [@bib2], [@bib29]. Presentation of PJI due to *S lugdunensis* can vary widely between acute symptoms such as fever and local site inflammation to unexplained dull aching pain at the site of surgery. Delay between time of surgery and presentation can be as short as 3 weeks [@bib29] or as long as 10 years [@bib24].Table 1Summary of *S lugdunensis* PJI cases reported in the literature.ReferenceNo.Age (range)GenderComorbiditiesDurationSiteSampathkumar et al. [@bib8]272MMG, cancer pancreas, asthma4 yTKR74MCancer prostate6 wkTKRWeightman et al. [@bib18]172M10 moTKRSanzeni and Ringberg [@bib19]154M2 yTHRLosada et al. [@bib20]169MRheumatoid arthritis treated with steroids and cyclosporinTKRFrank et al. [@bib21]6Lecuire et al. [@bib22]7(34-86)From 6 wk up to 9 y and 8 mo4 TKR, 3 THRTrampuz et al [@bib23]3Shah et al. [@bib2]28(35-88)14 M, 14 F3 DM, 5 on steroids, 9 urogenital abnormalities25 TKR, 3 THRHarris et al. [@bib12]8Merino et al. [@bib24]151MMultiple myeloma10 yTHRSzabados et al. [@bib9]147MDM, HBV2.5 yTHRTsaras et al. [@bib25]3Tande et al. [@bib15]5Campoccia et al. [@bib26]42 TKR, 2 THRPeel et al. [@bib27]7Marmor et al. [@bib28]96 TKR, 3 THRLourtet-Hascoet et al. [@bib29]28(58-78)13 M, 15 F4 CVD, 2 cancer, 1 DM, 1 rheumatoid disease3-56 wk16 TKR, 10 THR, 1 foot, 1 shoulderArgemi et al. [@bib30]170F2 yTKR[^1]

The method of treatment could be determined in 69 episodes reported in the literature. Two-stage revision was used in 30 episodes (43.5%), debridement, antibiotics, and implant retention (DAIR) in 24 episodes (34.8%), and 1-stage revision in 9 episodes (13%). However, comparison of the success rate of different strategies was not possible because of the lack of universal definition of a successful treatment and the scarcity of information regarding the success of treatment of each strategy. In the absence of clear recommendations for optimal surgical management of *S lugdunensis* PJI and bearing in mind its similar virulence, it should be treated as *S aureus* rather than CoNS [@bib29].

In a report of 38 PJI patients infected with staphylococcal SCVs, 3 patients were infected by *S lugdunensis* SCV [@bib15]. More recently, a case of normal variant *S lugdunensis* PJI who was initially treated by DAIR, developed a persistent infection 1 year later, and SCVs were isolated [@bib30]. This highlights the importance of not underestimating the pathogenicity of *S lugdunensis*. Unlike our case, emergence of SCV in the aforementioned case was most likely due to prior antibiotic use after the DAIR procedure (ofloxacin and rifampicin for 3 months). In our case, SCV had similar susceptibilities to antibiotics as the parent strain which could be explained by it not being induced by antibiotics.

In our case, quantitative bacterial growth from the sonicate was approximately 10-fold higher than the tissue homogenate. Sonication of retrieved implants has shown higher diagnostic sensitivity than periprosthetic tissue samples in both conventional and molecular diagnostic methods of PJI [@bib23], [@bib31]. Therefore, we recommend the use of sonication to enhance the detection and identification of the infecting bacteria and their SCVs in particular. In addition, prolonged incubation of aerobic culture to 72 hours and meticulous inspection of the agar plates are necessary to avoid missing SCVs.

Summary {#sec4}
=======

SCVs are hard to detect and identify by microbiologists in comparison to the parent strain. They can also lead to persistent, latent, or recurrent infections. SCVs are more likely to be associated with prolonged antimicrobial use and more chronic symptoms. Surgeons and microbiologists should be alert to the possibility of misidentified organisms or existence of SCVs when unexplained treatment failure happens.
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